Angion Biomedica Corp. and _____________, As Warrant Agent Form of Preferred Stock Warrant Agreement Dated As Of __________ ANGION BIOMEDICA CORP. FORM OF PREFERRED STOCK WARRANT AGREEMENTPreferred Stock Warrant Agreement • May 16th, 2022 • Angion Biomedica Corp. • Pharmaceutical preparations • New York
Contract Type FiledMay 16th, 2022 Company Industry JurisdictionThis Preferred Stock Warrant Agreement (this “Agreement”), dated as of [●], between Angion Biomedica Corp., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
Angion Biomedica Corp. and _____________, As Warrant Agent Form of Common Stock Warrant Agreement Dated As Of __________ Angion Biomedica Corp. Form of Common Stock Warrant AgreementWarrant Agreement • May 16th, 2022 • Angion Biomedica Corp. • Pharmaceutical preparations • New York
Contract Type FiledMay 16th, 2022 Company Industry JurisdictionThis Common Stock Warrant Agreement (this “Agreement”), dated as of [●], between, Angion Biomedica Corp., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
Angion Biomedica Corp. and _____________, As Warrant Agent Form of Debt Securities Warrant Agreement Dated As Of __________ ANGION BIOMEDICA CORP. FORM OF DEBT SECURITIES WARRANT AGREEMENT Angion Biomedica Corp. Form of debt securities Warrant AgreementDebt Securities Warrant Agreement • May 16th, 2022 • Angion Biomedica Corp. • Pharmaceutical preparations • New York
Contract Type FiledMay 16th, 2022 Company Industry JurisdictionThis Debt Securities Warrant Agreement (this “Agreement”), dated as of [●], between Angion Biomedica Corp., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
ANGION BIOMEDICA CORP. Common Stock ($0.01 par value per share) AT-THE-MARKET EQUITY OFFERING SALES AGREEMENTAt-the-Market Equity Offering Sales Agreement • May 16th, 2022 • Angion Biomedica Corp. • Pharmaceutical preparations • New York
Contract Type FiledMay 16th, 2022 Company Industry Jurisdiction